Pfizer describes absorption of Wyeth ops; NanoSonic to make pulse-dried APIs;

> A Pfizer senior VP describes the big pharma's initiative to integrate manufacturing and outsourcing activities in the wake of the Wyeth acquisition. 12-minute Podcast

> CTD Holdings has launched NanoSonic Products, a subsidiary with the goal of using pulse dryer technology to produce c-GMP dry APIs by end of year. Release

> Canadian regulators have given Dynavax the go-ahead to start testing the lot-to-lot consistency of commercial vaccine and to complete the safety database for the HEPLISAV hepatitis B vaccine candidate. Announcement

> Quebec-based vaccine developer Medicago, which uses virus-like particle and proprietary manufacturing technologies, will present at this week's 6th WHO meeting on evaluation of pandemic influenza prototype vaccines in clinical trials. Release

> Linguamatics, a U.K.-based text-mining platform provider for life sciences enterprises, has opened a U.S. facility in Newton, MA, just outside Boston. Release

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.